WO1998051265A1 - Composition for treating hair - Google Patents
Composition for treating hair Download PDFInfo
- Publication number
- WO1998051265A1 WO1998051265A1 PCT/US1997/019338 US9719338W WO9851265A1 WO 1998051265 A1 WO1998051265 A1 WO 1998051265A1 US 9719338 W US9719338 W US 9719338W WO 9851265 A1 WO9851265 A1 WO 9851265A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hair
- amino acids
- hydrolyzed protein
- vitamin
- cationic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/004—Preparations used to protect coloured hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
Definitions
- the present invention relates to a hair treatment composition which provides an excellent finishing effect and superior protection against environmental, chemical and grooming-associated damage.
- the compositions of the present invention comprise hydrolyzed protein having an abundance of anionic amino acids and in particular, sulphur-containing amino acids, as well as divalent cationic compounds, such that the anionic components of the hydrolyzed protein may effectively bind to the hair by means of cationic bridges. While bound to the hair, the sulphur containing amino acids in the hydrolyzed protein may serve as "decoys" for the effects of a variety of damaging agents.
- the compositions of the present invention may further comprise a vitamin compound which enhances these protective benefits.
- Human hair is comprised of keratin ("hair keratin”), a tough fibrous protein having a high sulfur content. Hair keratin is routinely exposed to a variety of activities that compromise its structure. For example, simple grooming and styling results in loss of cuticle scale, subjecting the hair's inner cortex to further damage and eventually leading to hair breakage. Shampooing causes frictional damage to cuticle scale and extracts hair protein. Ultraviolet light from the sun reduces the hair's mechanical strength and causes fading of natural and applied hair color. Exposure to chlorinated water in swimming pools causes oxidation of hair keratin, leading to increased protein loss during combing and brushing.
- the present invention relates to a composition
- a composition comprising an effective amount of an anionic hydrolyzed protein containing an abundance of sulphur-containing amino acids, which effectively binds to the anionic surface of hair via divalent cationic bridges.
- Such a composition when applied to the hair, reduces hair damage and protein loss caused by grooming, excessive heat, chlorinated water, ultraviolet light from the sun, and reactive chemicals.
- the addition of a vitamin compound which has antioxidant and/or ultraviolet absorbent properties further enhances the protective efficacy of the compositions of the present invention.
- the present invention provides for a hair treatment composition
- a hair treatment composition comprising: (a) from about 0.1 to about 50% by weight of a hydrolyzed protein, wherein the molar ratio of anionic amino acids to cationic amino acids is at least about 1.1 to 1.0, and wherein the hydrolyzed protein has an average molecular from about 200 to 500,000 daltons and comprises at least 0.25% by weight of sulphur-containing amino acids;
- Figure la is a bar graph illustrating the change in lightness of irradiated hair swatches treated with solutions containing varying molar ratios of divalent cationic compounds to hydrolyzed protein from wheat.
- Figure lb is a bar graph illustrating the change in color of irradiated hair swatches treated with solutions containing varying molar ratios of divalent cationic compounds to hydrolyzed protein from wheat.
- Figure lc is a bar graph illustrating the change in lightness of irradiated hair swatches treated with varying molar ratios of divalent cationic compounds to hydrolyzed protein from milk.
- Figure Id is a bar graph illustrating the change in color of irradiated hair swatches treated with varying molar ratios of divalent cationic compounds to hydrolyzed protein from milk.
- Figure 2 is a bar graph illustrating the mechanical strength of irradiated hair treated with hydrolyzed protein alone or in combination with divalent cationic compounds.
- Figure 3 is a bar graph illustrating the effect of chlorinated water on hair treated with hydrolyzed protein alone or in combination with divalent cationic compounds.
- Figure 4 is a bar graph illustrating the effect of extended periods of irradiation to hair treated with either hydrolyzed protein alone or in combination with divalent cationic compounds.
- Figure 5 is a bar graph comparing the protective effects of hydrolyzed protein from wheat and hydrolyzed protein from collagen, which were either succinylated or sulfonated.
- Figure 6 is a bar graph illustrating the effect of irradiating hair treated with hydrolyzed protein, divalent cationic compounds and vitamin compounds.
- Figure 7 is a bar graph illustrating the efficacy of hydrolyzed protein, divalent cationic compounds and vitamin compounds in retarding protein loss from hair.
- Figure 8 is a three dimensional graph illustrating the mechanical strength of irradiated hair treated with hydrolyzed protein, divalent cationic compounds and vitamin compounds.
- Figure 9 is a three dimensional graph illustrating the mechanical strength of irradiated and combed normal, bleached and permed hair treated with hydrolyzed protein, divalent cationic compounds and vitamin compounds.
- Figure 10 is a bar graph illustrating the change in color of irradiated hair swatches treated with solution containing varying molar ratios of dibasic cationic amino acid compounds to hydrogen protein.
- compositions for treating hair which protect hair from photo damage, chemical damage and protein loss due to grooming activities including, but not limited to, combing, brushing, blow drying, curling and the like.
- Such compositions of the invention comprise a hydrolyzed protein, a divalent cationic compound, and preferably a vitamin compound, in a cosmetic carrier.
- compositions according to the present invention include, but are not limited to, shampoos, conditioners, hair treatment creams, styling gels, mousse, pump hair sprays and aerosol hair sprays, set lotions, blow styling lotions, hair color lotions, hair relaxing compositions, permanent wave first agents, and permanent wave second agents.
- the amount of hydrolyzed protein in these compositions is dependent on various considerations, such as product esthetics and the type of commercial product end- use desired, for example, as a shampoo, cream or treatment conditioner for normal hair, oily hair, dry hair, permed hair, thick hair, fine hair, etc.
- the considerations regarding the appropriate amount of hydrolyzed protein to be used in view of the end-use would be known to those of ordinary skill in the art.
- products such as shampoos utilize relatively less hydrolyzed protein, generally in the range of 0.1 - 1.0% by weight of the composition, as the substantivity from shampoos is lower due to their detergency.
- compositions may contain up to 50%o by weight of hydrolyzed protein.
- compositions of the present invention comprise from about 0.1 to 50.0%) by weight, preferably from about 0.1 to 10.0% by weight, and more preferably from about 0.1 to 4.0% by weight of a hydrolyzed protein.
- hydrolyzed protein refers to the product of the hydrolysis of homogeneous or heterogeneous proteins, or their respective components, derivatives or combinations thereof, from sources including, but not limited to, plants and their respective components, seeds, animal bones, connective tissue, animal keratin, bovine and porcine collagen, human hair, wool, silk, elastin, reticulin, milk, egg, wheat, corn, soya, oats, casein, albumin, or any collagenous or keratinic substance, or derivatives thereof.
- compositions of the present invention there is no restriction on the source of protein, protein components or derivatives, provided that the hydrolyzate has the desired physical properties described herein.
- preferred protein sources include keratin, soya, milk, collagen, wheat and their respective components, derivatives or combinations thereof. Additional preferred protein sources may be identified as proteins having desirable amino acid compositions, as set forth below.
- Suitable derivatives include proteins chemically modified to alter their ionic charge, for example, by sulfonation or succinylation.
- the compositions of the present invention are not limited to hydrolyzed proteins produced from naturally occurring proteins.
- Synthetic proteins, peptides, or amino acids as well as naturally occurring proteins, peptides or amino acids or mixtures of naturally occurring and synthetic proteins and/or peptides and/or amino acids may also be used according to the invention.
- Hydrolyzed protein prepared from various proteins, their respective components, and derivatives may be combined and used in the composition of the present invention.
- a hydrolyzed protein may be supplemented by the addition of one or more natural or synthetic peptides or amino acids to achieve the ionic characteristics or sulphur content discussed below.
- hydrolyzed proteins from the above-mentioned protein sources include, but are not limited to: 1) acid hydrolysis; 2) alkali hydrolysis; and 3) enzyme hydrolysis using a suitable protease. These methods, along with several others, for preparing hydrolyzed proteins are well known in the art. Further, hydrolyzed proteins suitable for the compositions of the present invention are commercially available. Hydrolyzed proteins typically have an average molecular weight from about two hundred to several hundred thousand daltons, depending on the nature of the protein and/or the extent of hydrolysis. While hydrolyzed proteins of low molecular weight favor absorption, they are more easily lost from the hair by subsequent washing. On the other hand, proteins of very high molecular weight do not penetrate well.
- an average molecular weight of 500,000 daltons or less is desirable for hydrolyzed proteins utilized in this invention.
- the average molecular weight of the hydrolyzed protein is from about 200 to 500,000 daltons, preferably from about 200 to 100,000 daltons, more preferably from about 200 to 50,000 daltons, and even more preferably from about 200 to 20,000 daltons.
- the above-mentioned proteins or their derivatives, synthetic peptides, natural peptides or combinations thereof may be comprised in the composition of the present invention without any additional hydrolysis treatment, provided that the desired molecular weight, ionic characteristics and sulphur content set forth below may be achieved.
- Every protein molecule can be considered as a polymer of amino acids.
- Amino acids are commonly classified as either neutral, anionic or cationic amino acids based on the charge of the variable side chain.
- the naturally occurring anionic amino acids include aspartic acid and glutamic acid, both of which have a carboxylate group at the termini of their respective variable side chains.
- the present invention also provides for amino acids modified such that the net charge of the amino acid is made anionic, or if the net charge is already anionic, such charge may be increased. Examples of such modifications include, but are not limited to, succinylation or sulfonation of the amino acid. All such amino acids are considered, herein, to be "anionic amino acids.”
- the naturally occurring cationic amino acids include lysine, arginine and histidine, all of which comprise an amino group in their respective variable side chains. Amino acids may also be modified to result in a net cationic charge.
- amino acids are considered herein to be "cationic amino acids".
- Hair care products are generally in the pH range of 2.0 to 10.0. Proteins having a predominance of anionic amino acids, relative to cationic amino acids, are likely to be negatively charged at the general pH range of hair care products. Conversely, proteins having a relative abundance of cationic amino acids are likely to be positively charged under similar conditions. It is preferred that the amino acid composition of the hydrolyzed protein in the present invention contain a predominance of anionic amino acids relative to cationic amino acids, so that the hydrolyzed protein at the general pH range of hair care products is negatively charged.
- the composition of the present invention preferably comprises a hydrolyzed protein, wherein the molar ratio of anionic amino acids to cationic amino acids is at least 1.1 :1, preferably from about 1.1 :1 to 1.1 : 1 to 25 : 1 , and more preferably from about 1.1 to 1.1 :1 to 15:1.
- the molar ratio of anionic amino acids to cationic amino acids may be readily calculated based on the overall amino acid composition of the hydrolyzed protein or mixtures of hydrolyzed proteins. Such compositions are frequently known in the art. Alternatively, the amino acid composition of any protein may be determined using techniques known to those skilled in the art, which include, but are not limited to, (1) automated amino acid analysis and (2) high pressure liquid chromatography. Such techniques separate the individual amino acids, and the molar ratio of anionic to cationic amino acids may be determined.
- the hydrolyzed protein of the present invention is characterized in that it comprises at least 0.25%>, preferably from about 0.25 to 15%>, and more preferably from about 0.25 to 5.0%> by weight of a sulphur containing amino acid.
- the "term sulphur-containing amino acid” as used herein refers to any amino acid, natural or synthetic, containing sulphur in any form, including, but not limited to, sulphydryl groups or disulphide bonds.
- Sulphur-containing amino acids suitable for the present invention include, but are not limited to, cysteine, cystine, methionine, and their respective derivatives and synthetic analogues.
- compositions according to the present invention may, in particular embodiments, comprise in addition to the protein hydrolyzate, sulphur- containing compounds such as amino acids or sulphur-containing salts which may supplement the amount of sulphur in the composition to achieve the percentages (by weight, relative to the hydrolyzed protein) set for the above.
- sulphur-containing compounds such as amino acids or sulphur-containing salts which may supplement the amount of sulphur in the composition to achieve the percentages (by weight, relative to the hydrolyzed protein) set for the above.
- sulphur-containing amino acids in the hydrolyzed protein shield the hair from various assaults, such as exposure to ultraviolet light or chemicals known to cause hair damage. Without being bound by any theory, it is believed that the sulphur- containing amino acids act as a buffer or "decoy" between the hair and the assaulting agent.
- additional compounds having sulphydryl groups or disulphide bonds may be added to the compositions of the present invention to enhance protection from oxidation and ultra-violet light.
- free residual cystine such as cystine diester hydrochloride or any other sulphur-containing salt, may be added to increase the content of disulphide bonds present in the composition.
- peptide fragments rich in sulphur-containing amino acids or any other compound having sulphydryl groups or disulphide bonds may be used in the present invention.
- Synthetic or naturally occurring proteins and hydrolyzed proteins suitable for the present invention can be readily prepared from approriate sources, or, alternatively, purchased commercially.
- Table 1 sets forth relevant characteristics of nonlimiting examples of preferred protein sources from which the hydrolyzed proteins of the present invention may be prepared. These proteins were purchased from Croda, Inc. of Edison, New Jersey.
- Hair care products are generally in the pH range of 2.0 to 10.0, although products for shampooing, conditioning and treatment of the hair are more generally in the range of 3.5 to 10.0, and even more typically between the pH of about 3.5 and 8.0.
- the surface of the hair fiber has a predominance of negative charges, so that the divalent cationic compound is more effective at assisting with protein binding.
- the preferred pH of the composition of the present invention is between 2.0 to 10.0, preferably from about 3.5 to about 10.0, and more preferably from about 3.5 to about 8.0.
- compositions of the invention also comprise a divalent cationic compound, for example, a divalent mineral cation, including, but not limited to, divalent calcium, copper, magnesium, manganese, iron, strontium, zinc, cadmium, barium, silver, nickel, cobalt or mercury.
- the divalent mineral may preferably be obtained from an ionic salt, including, but not limited to, salts formed with carboxylate, sulfonate, phosphate, halide, carbonate, silicate, nitrate, or pantothenate ions.
- divalent non-mineral compounds may be used in the composition of the present invention, including, but not limited to, a peptide that comprises at least two cationic amino acids, such as, for example, histidine, arginine, lysine, orinithine hydroxylysine, their respective derivatives, analogues or combinations thereof, such that the peptide has a net divalent cationic charge.
- the divalent cationic charge may result from the presence of cationic amino acids of a single type, or multiple types.
- Such a peptide may comprise from at least 2 to about 200 amino acids, preferably between 2 to 10 amino acids.
- the molar ratio of the divalent non-mineral compound to anionic amino acids of the hydrolyzed protein is at least 0.2: 1 to 4: 1 , preferably between about 0.5 : 1 to
- the ratio of the cationic amino acids of the divalent non-mineral compound to the anionic amino acids of the hydrolyzed protein is at least 0.4:1 to 8:1, preferably between about 1 :1 to 2: 1, and more preferably at about 1 :1.
- peptides having a net cationic charge greater than 2 may be used in the composition of the present invention, including, but not limited to , a peptide that comprises at least two cationic amino acids, such as, for example, histidine, arginine, lysine, orinithine hydroxylysine, their respective derivatives, analogues or combinations thereof.
- a peptide may comprise from at least 2 to about 200 amino acids, preferably between 2 to 10 amino acids.
- the ratio of the cationic amino acids of the peptide to the anionic amino acids of the hydrolyzed protein is at least 0.4: 1 to 8:1, preferably between about 1 :1 to 2: 1 , and more preferably at about 1.0:1.
- divalent non-mineral substances which may be used in the compositions of the present invention, include, but not are not limited to, diamino compounds having the general formula:
- R l 5 R 2 , R 3 , R 4 , and R 5 which may be the same or different, may be a hydrogen or an alkyl group, including but not limited to, a methyl, ethyl, isopropyl, butyl, or propyl group, such that the compound has a net divalent cationic charge.
- the molar ratio of the diamino compound to the anionic amino acids of the hydrolyzed protein is at least 0.2: 1 to 4: 1 , preferably between about 0.5 : 1 to 1 :1 , and more preferably at about 1 :1.
- the ratio of the amino groups of the diamino compound to the anionic amino acids of the hydrolyzed protein is at least 0.4:1 to 8: 1 , preferably between 1.0:1 to 2:1, and more preferably at about 1 :1.
- cationic polyamino compounds which may be used in the compositions of the present invention include compounds having at least three amino groups.
- Such cationic polyamino compounds may include compounds having the general formula:
- R R 2 , R 3 , R 4 , and R 5 which may be the same or different, may be a compound comprising one or more amino groups or a hydrogen or an alkyl group, including but not limited to, a methyl, ethyl, isopropyl, butyl, or propyl group.
- the ratio of the amino groups of the cationic polyamino compound to the anionic amino acids of the hydrolyzed protein is between about 0.4:1 to 8:1, preferably between about 1.0:1 to 2:1, and more preferably about 1 :1.
- polyethylenimine C 2 H 5 N
- n from about 1-100, or greater.
- POLYMINEPEI® sold by BASF of New Jersey. Its molecular weight is between about 800 to 750,000.
- Another compound comprising at least three amino groups and which may be used in the present invention includes polyamidoamine. Such compound is sold under the brand-name STARBURST PAMAM by Dendritech, Inc. of Michigan.
- polyamino cationic compounds which may be used in the compositions of the present invention include cationic amino acid compounds.
- cationic amino acid compound as used in the specification and claims, is defined to include within the scope of that term any amino acid having an amino group in its variable side chain, such as, for example, histidine, lysine, arginine, hydroxylysine, ornithine, their respective derivatives, analogues, and stereoisomeric configurations or combinations thereof.
- Derivatives of the cationic amino acid compound may include salt forms of the amino acid.
- the cationic amino acid of the present invention may comprise a salt selected from the group consisting of hydrochloride, hydrochloride monohydrate, monohydrochloride, monohydrate, methyl ester dihydrochloride, dihydrochloride, ethyl ester dihydrochloride or combinations thereof.
- cationic amino acid compounds which may be suitable for the present invention include the following:
- the molar ratio of the cationic amino acid compound to anionic amino acids of the hydrolyzed protein is at least 0.2:1 to 4:1, preferably between about 0.5:1 to 1 :1, more preferably at about 0.5:1. Stated another way, the ratio of the amino groups of the cationic amino acid compound to anionic amino acids of the hydrolyzed protein is at least 0.4:1 to 8:1, preferably between about 1.0 and 2:1, and more preferably at about 1 :1.
- the molar ratio of divalent compound to the anionic amino acids of the hydrolyzed protein is effective in "bridging" the hydrolyzed protein to the hair to form a hydrolyzed protein layer, wherein said layer is effective in at least partially protecting the hair from photo damage, oxidation and grooming-associated damage.
- the preferred molar ratio of divalent cationic compound to anionic amino acids of the hydrolyzed protein is between about 0.2:1 to 4:1, preferably between about 0.5:1 to 1 :1, and more preferably at about 0.5:1.
- Examples 1-5 demonstrate the correlation between the molar ratio of divalent cationic compound to the anionic amino acids of the hydrolyzed protein and the protective effects of the compositions of the present invention.
- composition of the invention may further comprise from about 0.01 to 5%> by weight of a vitamin compound or its respective derivative which functions as an antioxidant and/or absorbs ultraviolet light.
- a vitamin compound or its respective derivative which functions as an antioxidant and/or absorbs ultraviolet light.
- the antioxidant vitamin is more readily oxidized than hair and hence can retard or inhibit the oxidation of the hair when applied.
- the vitamin compound may alternatively or additionally absorb ultra-violet light within the wavelength region between 290 and 420 nm, such that the vitamin may protect hair from photo damage when comprised in a composition of the invention.
- Suitable vitamin compounds and their respective derivatives falling within the scope of the present invention include, but are not limited to, the following:
- Vitamin Derivative Vitamin A (Retinol) Retinyl Palmitate Pro Vitamin A (Beta-Carotene) Vitamin B, (Thiamine) Thiamine Nitrate
- Vitamin B 3 Niacinamide
- Vitamin B 5 Purothenic Acid
- Vitamin B 6 Pyridoxine
- Pyridoxine Pyridoxine Dilaureate Pyridoxine Dioctenoate Pyridoxine Dipalmitate Pyridoxine Tripalmitate
- Vitamin B 12 (Cyanocobalamin)
- Vitamin C Ascorbic Acid
- Ascorbyl Palmitate Ascorbyl
- Glucoseamine Ascorbyl Dipalmitate Ascorbyl Stearate
- Vitamin D 2 (Ergocalciferol)
- Vitamin D 3 (Cholecalciferol)
- Vitamin E Tocopherol
- Tocopheryl Acetate Tocopheryl Linoleate
- Tocopheryl Nicotinate Tocopheryl Succinate
- Vitamin F Lileic, Linolenic acids
- Vitamin K (Phylloquinone)
- the above-mentioned vitamin compounds and their respective derivatives absorb ultra-violet light within the wavelength region between 290 and 420 nm.
- Vitamin compounds and their respective derivatives may be combined and used in the composition of the present invention.
- Examples 6-11, below, demonstrate that applying a composition comprising an anionic hydrolyzed protein comprising sulphur-containing amino acids, a divalent cationic compound and a vitamin compound to the hair provides substantial protection from photo damage, chemical damage and damage caused by grooming.
- the composition of the present invention comprises from about 1 to
- cosmetic carrier means the components, other than hydrolyzed protein, divalent cationic compound and vitamin compound, which are generally used in the cosmetic compositions within the scope of the present invention.
- cosmetic compositions may include, but are not limited to, shampoos, conditioners, hair treatment creams, styling gels, mousse, pump hair sprays and aerosol hair sprays and foams, set lotions, blow styling lotions, hair color lotions, hair relaxing compositions, permanent wave first agents, and permanent wave second agents.
- cosmetic carriers include, but are not limited to, water, aqueous solutions, detergents, emollients, surfactants, foam boosters, thickeners, fatty esters, ethers, alcohols, polymers, preservatives, color, dyes, fragrance and other ingredients known to those skilled in the art.
- compositions of the present invention were tested for beautifying effects and performance by skilled hairdressers. Based on such tests, the compositions were found to impart an excellent look, smoothness, feel and shine to the hair, as well as to provide excellent comability under wet and dry conditions. It was also observed that the compositions of the present invention made the hair more manageable, indicating that such compositions were effective as moisturizing, softening and bodifying treatments. Hair may be treated with the compositions of the present invention by applying effective amounts to the hair. When the composition of the present invention is present in the form of a shampoo or conditioner, the application is usually followed by rinsing the hair with water and finally drying the hair. When the composition of the present invention is a conditioner, treatment cream, styling gel or mousse, it may alternatively be retained in the hair or rinsed.
- compositions of the present invention may be separated and applied to the hair in effective amounts by applying such amounts in multiple steps to treat the hair as may be practiced with such products as perm waves, hair straighteners and hair relaxers.
- the protein and divalent cationic compound may be in the waving solution and the vitamin compound applied as a separate step before neutralizing the hair.
- polyamino cationic agent as recited in the specification and claims, is defined to include within the scope of that term any positively charged compound having a plurality of positively charged amino groups including, but not limited to, the compounds referenced in the specification and claims.
- Phenylenediamine sulfate/m-Phenylenediamine("o-Cl-PPD/MPD”) and then treated with one of the following solutions for 10 minutes at 40 °C: a) water b) 3%> by weight of hydrolyzed protein from wheat (Cropeptide W); c) 3%o by weight of hydrolyzed protein from wheat (Cropeptide W), wherein the molar ratio of the divalent cationic compound to anionic acidic amino acids in the hydrolyzed protein was either 0.1 :1, 0.5:1 , 1.0:1, 2.0:1 or 4.0:1.
- bleached hair swatches were colored with an oxidation dye, o- Chloro-p-Phenylenediamine sulfate/4-Ethoxy-m-phenylenediamine sulfate ("o-Cl- PPD/DAPS") and then treated with one of the following solutions for 10 minutes at 40°C: a) water b) 4%o by weight of hydrolyzed protein from milk (Hydrolactin); c) 4%> by weight of hydrolyzed protein from milk (Hydrolactin), wherein the molar ratio of the divalent mineral to anionic acidic amino acids in the hydrolyzed protein was either 0.1 : 1 , 0.5 : 1 , 1.0: 1 , 2.0: 1 or 4.0: 1.
- the divalent cationic compounds used were Mg ++ , Zn ++ , and Ca ++ from the salts gluconate and pantothenate.
- the molar ratios of divalent cationic compounds to anionic amino acids of the hydrolyzed protein were based on the total number of moles of the salt to the total number of moles of the anionic amino acids of the hydrolyzed protein used in the solution.
- the molar ratios of divalent cationic compounds to anionic amino acids of the hydrolyzed protein set forth in the remaining examples were calculated in the same manner as was described above.
- the o-Cl-PPD/MPD-treated hair swatches in the above-mentioned solutions were irradiated in a Weather-Ometer, which is a simulated sunlight exposure machine using a xenon arc lamp, for 5 hours.
- the o-Cl-PPD/DAPSD treated hair swatches in the above-mentioned solutions were exposed in the Weather-Ometer for 2 hours.
- the loss of "lightness" (change in L value) and blue color (change in b value) in the treated hair swatches were then determined according to the CIE L*A*B color difference system.
- Samples of treated hair were subjected to the following process up to three times (i.e., three cycles): (a) protein treated; (b) rinsed with water; (c) placed in a 1%>
- Normal brown hair was treated for 10 minutes at 40 °C with either a solution containing 25%) by weight of hydrolyzed protein from wheat (Cropeptide W) or 25%o by weight of hydrolyzed protein from wheat (Cropeptide W) together with divalent cationic minerals from the salts magnesium gluconate, zinc gluconate, and calcium pantothenate.
- the molar ratio of divalent cationic compound to anionic amino acids of the hydrolyzed protein was about 0.5:1.
- Samples of the treated hair were irradiated in the Weather-Ometer from 8 hours up to three days. The irradiated hair was then equilibrated at 25 °C at 50%> relative humidity for 24 hours and then stretched by the Instron Tester under the same conditions. The Fc value was obtained from the stress/strain curve and represents the condition of the hair, as described in Example 2.
- Normal brown hair was individually treated with the following: a) a solution containing 24%> by weight of hydrolyzed protein from wheat (Cropeptide W) and divalent cationic compounds from the salts zinc gluconate, magnesium gluconate, and calcium pantothenate; b) a solution containing 25% by weight of succinylated hydrolyzed protein from collagen and divalent cationic compounds from zinc gluconate, magnesium gluconate, and calcium pantothenate; and c) a solution containing 30%> by weight of sulfonated hydrolyzed protein from collagen and divalent cationic compounds from the salts zinc gluconate, magnesium gluconate, and calcium pantothenate.
- the molar ratio of the divalent cationic compounds to the anionic amino acids in the above- mentioned proteins was about 0.2: 1.
- the average molecular weight of succinylated or sulfonated proteins suitable for the present invention may be from 500 up to 500,000 daltons, or more.
- the treated hair was irradiated in the Weather-Ometer for 4 hours and then tested by the Instron at 25 °C, 50%> relative humidity. Based on the stress-strain curve, the condition of the hair was determined according to the Fc values, as described in Example 2. The results are shown in Figure 5.
- the succinylated and sulfonated hydrolyzed protein from collagen both significantly improved the condition of the hair.
- Bleached hair swatches were colored with an oxidation dye (o-Cl-
- the treated hair swatches were irradiated in the Weather-Ometer for 2 hours, and the loss of color (change in the b value) and lightness (change in the L value) was determined according to the CIE L*A*B color difference system. Minimum change in the b value or the L value represents negligible color loss due to the irradiation treatment.
- Table 2 The results shown below in Table 2 indicate that adding Vitamin A or Vitamin E to the hydrolyzed protein and divalent cationic compound mixture provided further protection against color loss.
- the pH range of the compositions described in Table 3 was from about
- the treated hair was irradiated in the Weather-Ometer for 24 hours.
- the irradiated hair samples were tested by the Instron Tester at 23 °C, 50%> relative humidity. Based on the stress/strain curves, the Condition Factor (Fc) values were determined using the same procedure described in Example 2 and the percent damage calculated.
- Fc Condition Factor
- divalent cationic compounds to the protein solution at about 0.6:1 molar ratio of cationic to anionic amino acids in the hydrolyzed protein
- the molar ratios of divalent cationic compounds to anionic amino acids of the hydrolyzed protein in both the shampoo and conditioner were about 1 : 1, and the ratio in the treatment composition was about 0.8:1.
- the pH range of the above-mentioned compositions was from about 4 to 6.
- Normal brown hair was treated with the treatment cream described below and irradiated in the Weather-Ometer for 2 hours.
- the treatment and irradiation steps were repeated up to 7 times (i.e., 7 cycles).
- the Fc values of the irradiated hair were determined by the Instron Tester, as described in Example 2, at 23 °C, 50%) relative humidity.
- the treatment cream contained the following: Self Emulsifying Glyceryl Ester 6.0%), Cetrimonium Chloride 3.5%o, Dicetyldimonium Chloride 3.0%>, Hydrolyzed protein from wheat 3.0%, Cetearyl Alcohol 2%>, Trimethylsylylamodimethicone 1.0%, Divalent Minerals 1.5% (Mg Gluconate 0.5%>, Zn Gluconate 0.5%>, and Ca Pantothenate 0.5%>), Vitamin Compounds 0.81% (Thiamine Hydrochloride 0.1 %>, Pyridoxine
- the molar ratios of divalent cationic compounds to anionic amino acids of the hydrolyzed protein in both the shampoo and conditioner were about 1 :1, and the ratio in the treatment composition was about 0.8:1.
- the pH range of the above-mentioned compositions was between about 4 and 6.
- compositions comprising hydrolyzed protein, divalent cationic compounds, and vitamin compounds in the proportions according to the present invention impart greater protection to the hair against excessive heat by grooming devices, such as blow dryers, curling irons and the like.
- the irradiated and combed hair was tested by the Instron Tester at 23 °C, 50%> relative humidity, as described in Example 2, to ascertain the Fc value (i.e., mechanical strength of the hair).
- the results are shown in Figure 9.
- the higher Fc values indicate that the condition of the hair treated with the shampoo, conditioner and treatment, as described in Table 4, was stronger and in better condition than the untreated hair. This suggests that the hydrolyzed protein/divalent cationic compound/vitamin compound mixture is effective in protecting bleached hair, permed hair, and normal from excessive combing and exposure to sunlight.
- Figure 10 shows test results measuring color loss in untreated hair and hair treated with compositions comprising a negatively charged hydrolyzed protein and polyamino cationic agent in various molar ratios.
- the testing reflected in Figure 10 was carried out as follows: (1) Bleached hair swatches were colored with an oxidation dye, o-Cl- p-Phenylenediamine sulfate/ m-Phenylenediamine("o-Cl-PPD/MPD”), and then treated with one of the following solutions for 10 minutes at 40°C:
- the cationic amino acid compound used in these tests was arginine hydrochloride (Brand name: L-Arginine Hydrochloride sold by Ajinomoto of Japan).
- the molar ratio of the cationic amino acid compound to anionic amino acids of the hydrolyzed protein were based on the total number of moles of the arginine to the total number of moles of the anionic amino acids of the hydrolyzed protein used in the solution.
- the o-Cl -PPD/MPD-treated hair swatches in the above-mentioned solutions were irradiated in a Weather-Ometer, which is a simulated sunlight exposure machine using a xenon arc lamp, for 5 hours.
- the loss of "lightness” (change in L value) in the treated hair swatches were then determined according to the CIE L*A*B* color difference between the change in the L value of treated hair and non-treated hair (i.e., hair treated with water alone).
- Percentage of improvement represents changes in L which reflects color loss due to the irradiation treatment. Compared to hair treated with the hydrolzyed protein and dibasic amino acid treated with the aforementioned molar ratios of dibasic amino acid compounds to anionic amino acids showed significantly less color loss. The expected value was determined by adding the separate effects of treating hair with protein and dibasic amino acid compounds alone.
- the level of protection obtained by treating hair with both protein and polyamino cationic agents in the molar ratios specified in the claims was greater than that achieved when hair was treated with either of the two components alone, and also greater than the expected protection from the additive combination of the hydrolyzed protein with the polyamino cationic agent.
- the polyamino cationic agent is arginine hydrochloride.
- the ratio of the arginine hydrochloride to anionic amino acids of the hydrolyzed protein in the above shampoo and protein hair treatment were about .6:1 to .9: 1.
- the pH range of these compositions was from about 4 to 6.
- the above compositions would provide a greater additive effect in protecting hair than the combined individual effects of the same or similar compositions containing the hydrolyzed protein or polyamino cationic agent alone.
- Various publications are cited herein, the contents of which are hereby incorporated by reference in their entireties.
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP54919298A JP2001525822A (en) | 1997-05-16 | 1997-10-27 | Hair treatment composition |
AU49991/97A AU746554B2 (en) | 1997-05-16 | 1997-10-27 | Composition for treating hair |
BR9714720-6A BR9714720A (en) | 1997-05-16 | 1997-10-27 | Composition for hair treatment. |
CA002289505A CA2289505C (en) | 1997-05-16 | 1997-10-27 | Composition for treating hair |
AT97912925T ATE244549T1 (en) | 1997-05-16 | 1997-10-27 | PRODUCTS FOR TREATING HAIR |
DE69723476T DE69723476T2 (en) | 1997-05-16 | 1997-10-27 | AGENT FOR TREATING HAIR |
PL97336840A PL336840A1 (en) | 1997-05-16 | 1997-10-27 | Hair-care composition |
EP97912925A EP0981318B1 (en) | 1997-05-16 | 1997-10-27 | Composition for treating hair |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/857,530 US6013250A (en) | 1995-06-28 | 1997-05-16 | Composition for treating hair against chemical and photo damage |
US08/857,530 | 1997-05-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998051265A1 true WO1998051265A1 (en) | 1998-11-19 |
Family
ID=25326204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/019338 WO1998051265A1 (en) | 1997-05-16 | 1997-10-27 | Composition for treating hair |
Country Status (15)
Country | Link |
---|---|
US (1) | US6013250A (en) |
EP (1) | EP0981318B1 (en) |
JP (1) | JP2001525822A (en) |
KR (1) | KR20010012619A (en) |
CN (1) | CN1163215C (en) |
AR (1) | AR013328A1 (en) |
AT (1) | ATE244549T1 (en) |
AU (1) | AU746554B2 (en) |
BR (1) | BR9714720A (en) |
CA (1) | CA2289505C (en) |
DE (1) | DE69723476T2 (en) |
ES (1) | ES2202593T3 (en) |
PL (1) | PL336840A1 (en) |
RU (1) | RU2197946C2 (en) |
WO (1) | WO1998051265A1 (en) |
Cited By (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001006994A1 (en) * | 1999-07-23 | 2001-02-01 | Unilever Plc | Method of reducing colour loss from dyed hair using organic amino compounds |
WO2001019327A1 (en) * | 1999-09-11 | 2001-03-22 | Henkel Kommanditgesellschaft Auf Aktien | Use of basic amino acids as blow-drying protection agents in hair treatment products |
WO2001097755A2 (en) * | 2000-06-20 | 2001-12-27 | Henkel Kommanditgesellschaft Auf Aktien | Vitamin b6 derivatives as protective components in the oxidative treatment of hair |
WO2001097760A1 (en) * | 2000-06-20 | 2001-12-27 | Henkel Kommanditgesellschaft Auf Aktien | Structure-improving hair care agents containing vitamin b6 and derivatives |
EP1252880A1 (en) * | 2001-04-24 | 2002-10-30 | Cognis Deutschland GmbH & Co. KG | Use of milk protein hydrolysates |
US6509011B1 (en) | 1999-07-23 | 2003-01-21 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Method of hair treatment using organic amino compounds |
KR100376538B1 (en) * | 2000-07-05 | 2003-03-17 | 씨제이 주식회사 | Hair shampoo composition reinforcing a fibroid material of interior of hair |
WO2003045340A1 (en) * | 2001-11-27 | 2003-06-05 | Unilever Plc | Hair treatment compositions |
WO2003051320A1 (en) * | 2001-12-18 | 2003-06-26 | Henkel Kommanditgesellschaft Auf Aktien | Method for the permanent deformation of keratin fibres, and agent |
KR100399831B1 (en) * | 2001-03-14 | 2003-09-29 | 씨제이 주식회사 | A hair conditioning comopsition |
EP1462086A1 (en) * | 2003-03-25 | 2004-09-29 | L'oreal | Use of a particular carboxylic acid or its salts as a conditioning agent for keratin materials |
FR2852824A1 (en) * | 2003-03-25 | 2004-10-01 | Oreal | Conditioners for keratin materials, especially hair, comprising polyhydroxy-carboxylic or substituted imino-polycarboxylic acids, impart good combability, softness and gloss to hair |
EP1466592A1 (en) * | 2003-04-07 | 2004-10-13 | Kao Corporation | Cleansing compositions |
EP1616556A1 (en) * | 2004-07-09 | 2006-01-18 | Mavi Sud S.R.L | Compostions comprising gelatin-glycine and carotenoids |
EP1800715A1 (en) * | 2005-12-23 | 2007-06-27 | Henkel Kommanditgesellschaft Auf Aktien | Cosmetic kit for the treatment of hair and scalp |
EP1813257A1 (en) * | 2006-01-31 | 2007-08-01 | Henkel Kommanditgesellschaft auf Aktien | Hair care composition comprising a casein hydrolysate |
WO2008006721A1 (en) * | 2006-07-14 | 2008-01-17 | Unilever Plc | Hair care composition |
US7465321B2 (en) | 2001-08-31 | 2008-12-16 | Keratec Limited | Production of biopolymer film, fibre, foam and adhesive materials from soluble S-sulfonated keratin derivatives |
US7579317B2 (en) | 2005-03-11 | 2009-08-25 | Keratec, Ltd. | Nutraceutical composition comprising soluble keratin or derivative thereof |
FR2939037A1 (en) * | 2008-12-02 | 2010-06-04 | Oreal | Topical or oral cosmetic use of combination of glycine, serine, valine and threonine, to prevent and/or treat soft, brittle, dull, refined and curly-hair, and improve softness and volume of the hair and its shine, in men |
US7732574B2 (en) | 2003-12-19 | 2010-06-08 | Keraplast Technologies, Ltd. | Wound care products containing keratin |
US7767756B2 (en) | 2003-09-19 | 2010-08-03 | Keraplast Technologies, Ltd. | Composite materials containing keratin |
US7892572B2 (en) | 2002-06-10 | 2011-02-22 | Keraplast Technologies, Ltd. | Orthopaedic materials derived from keratin |
EP2335780A1 (en) * | 2005-09-28 | 2011-06-22 | E. I. du Pont de Nemours and Company | Method for enhancing effects of colorants and conditioners |
US7998464B2 (en) | 2005-09-29 | 2011-08-16 | L'oreal S.A. | Process for the photoprotective treatment of artificially dyed keratin fibers by application of a liquid water/steam mixture |
US8124735B2 (en) | 2006-12-11 | 2012-02-28 | Keraplast Technologies, Ltd. | Porous keratin construct and method of making the same |
US8142807B2 (en) | 2006-12-06 | 2012-03-27 | Keraplast Technologies, Ltd. | Bone void fillers and methods of making the same |
WO2010005906A3 (en) * | 2008-07-09 | 2013-04-18 | Johnson & Johnson Consumer Companies, Inc. | Method and kit for the treatment of hair and keratin- based substrates comprising sequential addition of a cationic followed by an anionic compound |
US8691196B2 (en) | 2005-06-28 | 2014-04-08 | L'oreal | Photoprotective treatment of keratin fibers by application of heat |
WO2014095158A2 (en) * | 2012-12-21 | 2014-06-26 | Henkel Ag & Co. Kgaa | Method for the gentle heat-assisted shaping of keratin fibers |
US8790623B2 (en) | 2005-01-18 | 2014-07-29 | Il'Oreal | Composition for treating keratin fibers, comprising at least one aromatic alcohol, at least one aromatic carboxylic acid, and at least one protecting agent |
WO2014202653A1 (en) * | 2013-06-20 | 2014-12-24 | L'oreal | Method for the densification of keratinous fibres based on specific acrylic polymer and specific silicone compound |
WO2014202655A1 (en) * | 2013-06-20 | 2014-12-24 | L'oreal | Composition comprising a combination of an acrylic polymer, a silicone copolymer and an amino acid or amino acid derivative |
FR3015244A1 (en) * | 2013-12-23 | 2015-06-26 | Oreal | PROCESS FOR TREATING KERATIN FIBERS WITH ASCORBIC ACID COMPOUND |
US10159639B2 (en) | 2013-06-20 | 2018-12-25 | L'oreal | Composition comprising a combination of an acrylic polymer and an amino silicone |
US11628148B2 (en) | 2017-07-10 | 2023-04-18 | Wella Operations Us, Llc | Nail hardening composition and method of use |
Families Citing this family (97)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8039026B1 (en) * | 1997-07-28 | 2011-10-18 | Johnson & Johnson Consumer Companies, Inc | Methods for treating skin pigmentation |
US8093293B2 (en) * | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
US8106094B2 (en) * | 1998-07-06 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
US6750229B2 (en) | 1998-07-06 | 2004-06-15 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin pigmentation |
US20020197244A1 (en) * | 1998-12-07 | 2002-12-26 | Miri Seiberg | Compositions and methods for regulating phagocytosis and ICAM-1 expression |
US7985404B1 (en) * | 1999-07-27 | 2011-07-26 | Johnson & Johnson Consumer Companies, Inc. | Reducing hair growth, hair follicle and hair shaft size and hair pigmentation |
US7309688B2 (en) | 2000-10-27 | 2007-12-18 | Johnson & Johnson Consumer Companies | Topical anti-cancer compositions and methods of use thereof |
GB0004686D0 (en) * | 2000-02-28 | 2000-04-19 | Aventis Pharma Ltd | Chemical compounds |
FR2811550B1 (en) * | 2000-07-11 | 2003-02-14 | Oreal | COMPOSITION BASED ON VITAMINS AND MINERAL SALTS, FOR REDUCING HAIR LOSS AND / OR PROMOTING HAIR GROWTH |
US6455058B1 (en) | 2000-09-13 | 2002-09-24 | Amitee Cosmetics, Inc. | Composition and method for hair and scalp treatment |
US8431550B2 (en) * | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
US7192615B2 (en) * | 2001-02-28 | 2007-03-20 | J&J Consumer Companies, Inc. | Compositions containing legume products |
US6555143B2 (en) | 2001-02-28 | 2003-04-29 | Johnson & Johnson Consumer Products, Inc. | Legume products |
US7186275B2 (en) * | 2001-03-20 | 2007-03-06 | The Procter & Gamble Company | Compositions suitable for the treatment of hair comprising chelants and methods for reducing oxidative hair damage |
US7179302B2 (en) * | 2001-03-20 | 2007-02-20 | The Procter & Gamble Company | Oxidative treatment of hair with reduced hair damage |
US7622104B2 (en) * | 2001-08-20 | 2009-11-24 | L'oreal S.A. | Methods for relaxing and re-waving hair comprising at least one reducing agent and at least one hydroxide compound |
US20030224075A1 (en) * | 2002-02-21 | 2003-12-04 | Jue-Chen Liu | Soy composition for balancing combination skin |
ES2367258T3 (en) * | 2002-04-19 | 2011-10-31 | Arizona Board Of Regents On Behalf Of The University Of Arizona | METHODS TO MODULATE PHOTOTOXICITY. |
KR100458007B1 (en) * | 2002-05-01 | 2004-11-18 | 대한민국 | A composition for hairdye containing silk and wool protein |
US20040063593A1 (en) * | 2002-09-30 | 2004-04-01 | Wu Jeffrey M. | Compositions containing a cosmetically active organic acid and a legume product |
US7060260B2 (en) * | 2003-02-20 | 2006-06-13 | E.I. Du Pont De Nemours And Company | Water-soluble silk proteins in compositions for skin care, hair care or hair coloring |
EP1643967A1 (en) * | 2003-06-17 | 2006-04-12 | E.I. Dupont De Nemours And Company | Modified soy proteins in personal care compositions |
US20050004561A1 (en) * | 2003-07-01 | 2005-01-06 | Lynn Halas | Method for removing hair |
US7585495B2 (en) | 2003-09-08 | 2009-09-08 | E. I. Du Pont De Nemours And Company | Method for identifying shampoo-resistant hair-binding peptides and hair benefit agents therefrom |
US7285264B2 (en) * | 2003-09-08 | 2007-10-23 | E.I. Du Pont De Nemours And Company | Peptide-based body surface coloring reagents |
US7807141B2 (en) | 2003-09-08 | 2010-10-05 | E.I. Du Pont De Nemours And Company | Peptide-based oral care surface reagents for personal care |
CN102138869B (en) | 2003-09-08 | 2013-05-01 | 纳幕尔杜邦公司 | Peptide-based conditioner and colorant for hair, skin and nail |
US20100311641A1 (en) * | 2003-09-08 | 2010-12-09 | E. I. Du Pont De Nemours And Company | Peptide-based body surface coloring reagents |
US20050226839A1 (en) * | 2003-09-08 | 2005-10-13 | Xueying Huang | Pepetide-based body surface reagents for personal care |
US7220405B2 (en) * | 2003-09-08 | 2007-05-22 | E. I. Du Pont De Nemours And Company | Peptide-based conditioners and colorants for hair, skin, and nails |
BRPI0415977A (en) * | 2003-10-29 | 2007-01-23 | Johnson & Johnson Consumer Fr | compositions comprising soy products and dioic acids |
FR2887440B1 (en) * | 2005-06-28 | 2009-07-10 | Oreal | PROCESS FOR PHOTOPROTECTIVE TREATMENT OF KERATIN FIBERS BY HEAT APPLICATION |
US20070065387A1 (en) * | 2005-09-16 | 2007-03-22 | Beck William A | Method for enhancing the effect of particulate benefit agents |
EP1931702B1 (en) | 2005-10-05 | 2013-01-02 | Commonwealth Scientific And Industrial Research Organisation | Silk proteins |
US7928076B2 (en) * | 2005-12-15 | 2011-04-19 | E. I. Du Pont De Nemours And Company | Polypropylene binding peptides and methods of use |
US7906617B2 (en) | 2005-12-15 | 2011-03-15 | E. I. Du Pont De Nemours And Company | Polyethylene binding peptides and methods of use |
US7858581B2 (en) * | 2005-12-15 | 2010-12-28 | E. I. Du Pont De Nemours And Company | PMMA binding peptides and methods of use |
US7632919B2 (en) * | 2005-12-15 | 2009-12-15 | E.I. Du Pont De Nemours And Company | Polystyrene binding peptides and methods of use |
US7700716B2 (en) * | 2005-12-15 | 2010-04-20 | E. I. Du Pont De Nemours And Company | Polytetrafluoroethylene binding peptides and methods of use |
US7709601B2 (en) * | 2005-12-15 | 2010-05-04 | E. I. Du Pont De Nemours And Company | Nylon binding peptides and methods of use |
RU2008129097A (en) * | 2005-12-16 | 2010-01-27 | Унилевер Н.В. (NL) | COMPOSITIONS FOR TREATING HAIR |
EP1959917A1 (en) * | 2005-12-16 | 2008-08-27 | Unilever Plc | Hair treatment compositions |
DE602006015230D1 (en) * | 2005-12-16 | 2010-08-12 | Unilever Nv | HAIR TREATMENT COMPOSITIONS |
US7749957B2 (en) | 2006-04-06 | 2010-07-06 | E.I. Du Pont De Nemours And Company | Clay-binding peptides and methods of use |
KR100848382B1 (en) | 2006-05-08 | 2008-07-24 | 서명숙 | Cosmetic compositions and liquid for permanent wave utilizing the same |
US20080008818A1 (en) * | 2006-06-23 | 2008-01-10 | Miri Seiberg | Partially denatured whole soybean extracts and methods of use thereof |
US20080089960A1 (en) * | 2006-10-16 | 2008-04-17 | Miri Seiberg | Use of Legume Products for the Treatment and Prevention of Radiotherapy-Induced Skin Damage |
FR2907668B1 (en) † | 2006-10-26 | 2012-08-17 | Oreal | USE OF A ZINC-BASED COMPOUND FOR PROTECTING THE COLOR FROM THE WASHING OF ARTIFICIALLY ARTIFICIENT KERATIN FIBERS; COLORING PROCESSES |
US20080229521A1 (en) * | 2006-10-26 | 2008-09-25 | Boris Lalleman | Process for protecting the color of artificially dyed keratin fibers with respect to washing and light; dyeing processes |
US20080107614A1 (en) * | 2006-11-06 | 2008-05-08 | Fahnestock Stephen R | Peptide-based conditioners |
US8273337B2 (en) | 2007-09-14 | 2012-09-25 | Affinergy Inc. | Hair binding peptides and peptide-based hair reagents for personal care |
US8318797B2 (en) * | 2008-10-30 | 2012-11-27 | Presty S Katharine | Composition and methods for the protection of hair from treated pool water |
US20100158822A1 (en) | 2008-12-18 | 2010-06-24 | E .I. Du Pont De Nemours And Company | Peptides that bind to silica-coated particles |
US20100158837A1 (en) | 2008-12-18 | 2010-06-24 | E. I. Du Pont De Nemours And Company | Iron oxide-binding peptides |
US8697654B2 (en) | 2008-12-18 | 2014-04-15 | E I Du Pont De Nemours And Company | Peptide linkers for effective multivalent peptide binding |
US20100291018A1 (en) * | 2009-05-12 | 2010-11-18 | Alex Kim | Conditioner for eyelash and eyebrow |
SG178870A1 (en) | 2009-08-26 | 2012-04-27 | Commw Scient Ind Res Org | Processes for producing silk dope |
JP2013514261A (en) * | 2009-12-18 | 2013-04-25 | ロレアル | Method for treating keratin fibers |
FR2968940B1 (en) * | 2010-12-21 | 2013-04-19 | Oreal | COSMETIC COMPOSITION COMPRISING A PARTICULAR ZINC SALT AND AN AMINE SILICONE |
KR101428576B1 (en) * | 2011-02-28 | 2014-08-12 | 건국대학교 산학협력단 | Autolysate of Lugworm Marphysa sanguinea for Hair Improving and Composition of Hair Cosmetics Using Them Thereof |
CN103857440B (en) | 2011-06-22 | 2018-09-25 | 维奥姆生物科学有限公司 | Antimycotic and antibacterium prodrug based on conjugate |
JP5864943B2 (en) * | 2011-08-03 | 2016-02-17 | 株式会社ミルボン | Intermediate treatment agent for permanent wave |
JP6317258B2 (en) | 2011-11-16 | 2018-04-25 | コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション | Collagen-like silk gene |
EP2644186A1 (en) | 2012-03-26 | 2013-10-02 | OTC GmbH | Hair conditioning composition for permanent and semi-permanent hair coloration applications |
AU2013239320B2 (en) | 2012-03-26 | 2018-11-01 | Commonwealth Scientific And Industrial Research Organisation | Silk polypeptides |
US20140190507A9 (en) * | 2012-06-04 | 2014-07-10 | Jean Harry Xavier | Compositions And Methods For Enhancing The Structure Of Hair Fibers |
JP5765537B2 (en) * | 2012-08-03 | 2015-08-19 | 山栄化学株式会社 | Curling hair finish |
AU2014276460A1 (en) | 2013-06-04 | 2015-12-24 | Vyome Biosciences Pvt. Ltd. | Coated particles and compositions comprising same |
EP3277249A4 (en) * | 2015-04-03 | 2018-12-19 | Revlon Consumer Products Corporation | Keratin treatments |
MX2017013983A (en) | 2015-05-01 | 2018-03-15 | Oreal | Use of active agents during chemical treatments. |
JP6930994B2 (en) | 2015-11-24 | 2021-09-01 | ロレアル | Composition for treating hair |
CN108495687B (en) | 2015-11-24 | 2021-11-09 | 欧莱雅 | Composition for treating hair |
BR112018010344B1 (en) | 2015-11-24 | 2021-08-10 | L'oreal | HAIR COMPOSITION, HAIR TREATMENT SYSTEM AND METHOD, METHODS FOR CHANGING HAIR COLOR AND HAIR SHAPE, AND, MULTICOMPARTMENT KITS |
EP3175837A1 (en) * | 2015-12-01 | 2017-06-07 | Noxell Corporation | Method for treating hair |
US11389387B2 (en) | 2016-09-13 | 2022-07-19 | Basf Se | Protein hydrolysates |
US11135150B2 (en) | 2016-11-21 | 2021-10-05 | L'oreal | Compositions and methods for improving the quality of chemically treated hair |
CA3046223C (en) | 2016-12-16 | 2023-09-26 | E.I. Du Pont De Nemours And Company | Amphiphilic polysaccharide derivatives and compositions comprising same |
WO2018183869A1 (en) * | 2017-03-31 | 2018-10-04 | L'oreal | Kits and methods for treating hair |
US9974725B1 (en) | 2017-05-24 | 2018-05-22 | L'oreal | Methods for treating chemically relaxed hair |
EP3664773A4 (en) | 2017-08-11 | 2021-05-12 | Sytheon Limited | Hair treatment compositions and methods |
EP4011355A1 (en) | 2017-12-29 | 2022-06-15 | L'oreal | Compositions for altering the color of hair |
JP2021527158A (en) | 2018-06-20 | 2021-10-11 | デュポン・インダストリアル・バイオサイエンシーズ・ユーエスエイ・エルエルシー | Composition containing polysaccharide derivative and identical |
KR102076178B1 (en) * | 2018-07-18 | 2020-02-11 | 주식회사 코리아나화장품 | Cosmetic composition for improving skin wrinkle containing colostrum and ornithine |
US11090249B2 (en) | 2018-10-31 | 2021-08-17 | L'oreal | Hair treatment compositions, methods, and kits for treating hair |
US20220033531A1 (en) | 2018-12-17 | 2022-02-03 | Dupont Industrial Biosciences Usa,Llc | Polysaccharide Derivatives and Compositions Comprising Same |
CN110123670A (en) * | 2019-06-12 | 2019-08-16 | 四川大学 | A kind of dendritic macromole catalysis hair dye and its preparation and application |
US11419809B2 (en) | 2019-06-27 | 2022-08-23 | L'oreal | Hair treatment compositions and methods for treating hair |
US20210236398A1 (en) * | 2020-01-31 | 2021-08-05 | L'oreal | Compositions and methods for hair |
CN116134055A (en) | 2020-06-10 | 2023-05-16 | 营养与生物科学美国4公司 | Poly alpha-1, 6-glucan derivative and composition comprising same |
CN116157421A (en) | 2020-06-10 | 2023-05-23 | 营养与生物科学美国4公司 | Poly alpha-1, 6-glucan esters and compositions comprising the same |
WO2021257786A1 (en) | 2020-06-18 | 2021-12-23 | Nutrition & Biosciences USA 4, Inc. | Cationic poly alpha-1,6-glucan ethers and compositions comprising same |
US20240108565A1 (en) | 2021-02-02 | 2024-04-04 | Federici Brands, Llc | Composition comprising a hydrolyzed keratin and a silane crosslinking agent and process for hair protection during bleaching |
FR3135605A1 (en) | 2022-05-18 | 2023-11-24 | L'oreal | Process for cleaning human keratin materials |
FR3135603A1 (en) | 2022-05-18 | 2023-11-24 | L'oreal | Hair treatment device and method |
FR3135604A1 (en) | 2022-05-18 | 2023-11-24 | L'oreal | Device for treating human keratin materials |
WO2023222789A1 (en) | 2022-05-18 | 2023-11-23 | L'oreal | Device for treating human keratin materials |
CN115120524A (en) * | 2022-07-06 | 2022-09-30 | 澳宝化妆品(惠州)有限公司 | Quick-drying color-fixing hair washing composition containing triple hydrolyzed vegetable protein extract |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0052943A2 (en) * | 1980-11-20 | 1982-06-02 | Kao Soap Co., Ltd. | Hair setting composition |
EP0057837A2 (en) * | 1981-02-05 | 1982-08-18 | Kao Corporation | Hair treatment compositions |
EP0099780A1 (en) * | 1982-06-24 | 1984-02-01 | L'oreal | Keratin derivative, process for its preparation and treatment composition containing it |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3972998A (en) * | 1969-10-24 | 1976-08-03 | Lever Brothers Company | Hair preparation containing a fluoropolymer |
US3958581A (en) * | 1972-05-17 | 1976-05-25 | L'oreal | Cosmetic composition containing a cationic polymer and divalent metal salt for strengthening the hair |
LU72592A1 (en) * | 1975-05-28 | 1977-02-10 | ||
US4279996A (en) * | 1978-10-09 | 1981-07-21 | Seiwa Kasei Co., Ltd. | Keratin hydrolyzate useful as hair fixatives |
LU81257A1 (en) * | 1979-05-15 | 1980-12-16 | Oreal | COSMETIC COMPOSITION FOR THE TREATMENT OF HAIR AND SKIN, CONTAINING SALSEPAREILLE EXTRACT |
JPS5785308A (en) * | 1980-11-17 | 1982-05-28 | Kao Corp | Hair rinse composition |
JPS5791910A (en) * | 1980-11-28 | 1982-06-08 | Kao Corp | Preshampoo-type hair treatment composition |
JP2519024B2 (en) * | 1982-06-07 | 1996-07-31 | 花王株式会社 | Hair cosmetics |
US4542014A (en) * | 1982-12-03 | 1985-09-17 | The Gillette Company | Hair treating composition |
DE3470457D1 (en) * | 1983-02-25 | 1988-05-26 | Kao Corp | Hair cosmetics |
US5192332A (en) * | 1983-10-14 | 1993-03-09 | L'oreal | Cosmetic temporary coloring compositions containing protein derivatives |
JPS62205012A (en) * | 1986-03-03 | 1987-09-09 | Kao Corp | Hair deformation treating agent |
EP0269107A3 (en) * | 1986-11-28 | 1989-10-11 | Kao Corporation | Composition for hair treatment agent |
DE3837860A1 (en) * | 1988-11-08 | 1990-05-10 | Wella Ag | STORAGE HAIR CONDITIONER WITH PEARL GLOSS |
US4970067A (en) * | 1988-12-12 | 1990-11-13 | Helene Curtis, Inc. | Method and composition to condition hair and impart semi-permanent hair set retention properties |
DE3929740A1 (en) * | 1989-09-07 | 1991-03-14 | Hoechst Ag | HIGHLY MOLECULAR PROTEIN FATIGUE ACIDICONDUCTIVE PRODUCTS WITH VERY GOOD SKIN AND SWEATBAR CONFIDENTIALITY |
FR2658076B1 (en) * | 1990-02-12 | 1992-06-12 | Sanofi Sa | COSMETIC COMPOSITION CONTAINING COPOLYMERS OF AMINO ACIDS, USEFUL AS A MOISTURIZING AGENT. |
DE4009616A1 (en) * | 1990-03-26 | 1991-10-02 | Henkel Kgaa | LIQUID BODY CLEANER |
-
1997
- 1997-05-16 US US08/857,530 patent/US6013250A/en not_active Expired - Fee Related
- 1997-10-27 AR ARP970104970A patent/AR013328A1/en not_active Application Discontinuation
- 1997-10-27 EP EP97912925A patent/EP0981318B1/en not_active Revoked
- 1997-10-27 CN CNB971821925A patent/CN1163215C/en not_active Expired - Fee Related
- 1997-10-27 ES ES97912925T patent/ES2202593T3/en not_active Expired - Lifetime
- 1997-10-27 BR BR9714720-6A patent/BR9714720A/en not_active IP Right Cessation
- 1997-10-27 PL PL97336840A patent/PL336840A1/en unknown
- 1997-10-27 DE DE69723476T patent/DE69723476T2/en not_active Revoked
- 1997-10-27 JP JP54919298A patent/JP2001525822A/en not_active Withdrawn
- 1997-10-27 AT AT97912925T patent/ATE244549T1/en not_active IP Right Cessation
- 1997-10-27 WO PCT/US1997/019338 patent/WO1998051265A1/en not_active Application Discontinuation
- 1997-10-27 AU AU49991/97A patent/AU746554B2/en not_active Ceased
- 1997-10-27 RU RU99126865/14A patent/RU2197946C2/en not_active IP Right Cessation
- 1997-10-27 CA CA002289505A patent/CA2289505C/en not_active Expired - Fee Related
- 1997-10-27 KR KR1019997010579A patent/KR20010012619A/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0052943A2 (en) * | 1980-11-20 | 1982-06-02 | Kao Soap Co., Ltd. | Hair setting composition |
EP0057837A2 (en) * | 1981-02-05 | 1982-08-18 | Kao Corporation | Hair treatment compositions |
EP0099780A1 (en) * | 1982-06-24 | 1984-02-01 | L'oreal | Keratin derivative, process for its preparation and treatment composition containing it |
Non-Patent Citations (2)
Title |
---|
DATABASE "CHEMICAL ABSTRACTS" (HOST: STN):Abs.124: 211 493, Colombus, OH, USA; & JP 07 330 560 A (SHISEIDO CO., LTD) 19 DECEMBER 1995 * |
DATABASE "CHEMICAL ABSTRACTS" (HOST: STN);Abs.124: 269 956, Colmbus, OH, USA; & JP 08 020 518 A (SHISEIDO CO., LTD) 23 JANUARY 1996 * |
Cited By (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6551361B1 (en) | 1999-07-23 | 2003-04-22 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Method of hair treatment using organic amino compounds |
WO2001006994A1 (en) * | 1999-07-23 | 2001-02-01 | Unilever Plc | Method of reducing colour loss from dyed hair using organic amino compounds |
US6509011B1 (en) | 1999-07-23 | 2003-01-21 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Method of hair treatment using organic amino compounds |
AU754633B2 (en) * | 1999-07-23 | 2002-11-21 | Unilever Plc | Method of reducing colour loss from dyed hair using organic amino compounds |
WO2001019327A1 (en) * | 1999-09-11 | 2001-03-22 | Henkel Kommanditgesellschaft Auf Aktien | Use of basic amino acids as blow-drying protection agents in hair treatment products |
WO2001097755A2 (en) * | 2000-06-20 | 2001-12-27 | Henkel Kommanditgesellschaft Auf Aktien | Vitamin b6 derivatives as protective components in the oxidative treatment of hair |
WO2001097760A1 (en) * | 2000-06-20 | 2001-12-27 | Henkel Kommanditgesellschaft Auf Aktien | Structure-improving hair care agents containing vitamin b6 and derivatives |
WO2001097755A3 (en) * | 2000-06-20 | 2002-06-20 | Henkel Kgaa | Vitamin b6 derivatives as protective components in the oxidative treatment of hair |
US6787128B2 (en) | 2000-06-20 | 2004-09-07 | Henkel Kommanditgesellschaft Auf Aktien | Structure-improving hair care agents |
JP2003535880A (en) * | 2000-06-20 | 2003-12-02 | ヘンケル・コマンディットゲゼルシャフト・アウフ・アクチエン | Tissue improving hair care agent |
KR100376538B1 (en) * | 2000-07-05 | 2003-03-17 | 씨제이 주식회사 | Hair shampoo composition reinforcing a fibroid material of interior of hair |
KR100399831B1 (en) * | 2001-03-14 | 2003-09-29 | 씨제이 주식회사 | A hair conditioning comopsition |
EP1252880A1 (en) * | 2001-04-24 | 2002-10-30 | Cognis Deutschland GmbH & Co. KG | Use of milk protein hydrolysates |
US7465321B2 (en) | 2001-08-31 | 2008-12-16 | Keratec Limited | Production of biopolymer film, fibre, foam and adhesive materials from soluble S-sulfonated keratin derivatives |
WO2003045340A1 (en) * | 2001-11-27 | 2003-06-05 | Unilever Plc | Hair treatment compositions |
WO2003051320A1 (en) * | 2001-12-18 | 2003-06-26 | Henkel Kommanditgesellschaft Auf Aktien | Method for the permanent deformation of keratin fibres, and agent |
US7892572B2 (en) | 2002-06-10 | 2011-02-22 | Keraplast Technologies, Ltd. | Orthopaedic materials derived from keratin |
FR2852824A1 (en) * | 2003-03-25 | 2004-10-01 | Oreal | Conditioners for keratin materials, especially hair, comprising polyhydroxy-carboxylic or substituted imino-polycarboxylic acids, impart good combability, softness and gloss to hair |
EP1462086A1 (en) * | 2003-03-25 | 2004-09-29 | L'oreal | Use of a particular carboxylic acid or its salts as a conditioning agent for keratin materials |
EP1466592A1 (en) * | 2003-04-07 | 2004-10-13 | Kao Corporation | Cleansing compositions |
US7767756B2 (en) | 2003-09-19 | 2010-08-03 | Keraplast Technologies, Ltd. | Composite materials containing keratin |
US7732574B2 (en) | 2003-12-19 | 2010-06-08 | Keraplast Technologies, Ltd. | Wound care products containing keratin |
EP1616556A1 (en) * | 2004-07-09 | 2006-01-18 | Mavi Sud S.R.L | Compostions comprising gelatin-glycine and carotenoids |
US8790623B2 (en) | 2005-01-18 | 2014-07-29 | Il'Oreal | Composition for treating keratin fibers, comprising at least one aromatic alcohol, at least one aromatic carboxylic acid, and at least one protecting agent |
US7579317B2 (en) | 2005-03-11 | 2009-08-25 | Keratec, Ltd. | Nutraceutical composition comprising soluble keratin or derivative thereof |
US8691196B2 (en) | 2005-06-28 | 2014-04-08 | L'oreal | Photoprotective treatment of keratin fibers by application of heat |
EP2335780A1 (en) * | 2005-09-28 | 2011-06-22 | E. I. du Pont de Nemours and Company | Method for enhancing effects of colorants and conditioners |
US7998464B2 (en) | 2005-09-29 | 2011-08-16 | L'oreal S.A. | Process for the photoprotective treatment of artificially dyed keratin fibers by application of a liquid water/steam mixture |
EP1800715A1 (en) * | 2005-12-23 | 2007-06-27 | Henkel Kommanditgesellschaft Auf Aktien | Cosmetic kit for the treatment of hair and scalp |
EP1813257A1 (en) * | 2006-01-31 | 2007-08-01 | Henkel Kommanditgesellschaft auf Aktien | Hair care composition comprising a casein hydrolysate |
WO2008006721A1 (en) * | 2006-07-14 | 2008-01-17 | Unilever Plc | Hair care composition |
US8142807B2 (en) | 2006-12-06 | 2012-03-27 | Keraplast Technologies, Ltd. | Bone void fillers and methods of making the same |
US8124735B2 (en) | 2006-12-11 | 2012-02-28 | Keraplast Technologies, Ltd. | Porous keratin construct and method of making the same |
WO2010005906A3 (en) * | 2008-07-09 | 2013-04-18 | Johnson & Johnson Consumer Companies, Inc. | Method and kit for the treatment of hair and keratin- based substrates comprising sequential addition of a cationic followed by an anionic compound |
FR2939037A1 (en) * | 2008-12-02 | 2010-06-04 | Oreal | Topical or oral cosmetic use of combination of glycine, serine, valine and threonine, to prevent and/or treat soft, brittle, dull, refined and curly-hair, and improve softness and volume of the hair and its shine, in men |
WO2014095158A3 (en) * | 2012-12-21 | 2015-01-22 | Henkel Ag & Co. Kgaa | Method for the gentle heat-assisted shaping of keratin fibers |
WO2014095158A2 (en) * | 2012-12-21 | 2014-06-26 | Henkel Ag & Co. Kgaa | Method for the gentle heat-assisted shaping of keratin fibers |
US9681724B2 (en) | 2012-12-21 | 2017-06-20 | Croda International Plc | Method for the gentle heat-assisted shaping of keratin fibers |
WO2014202653A1 (en) * | 2013-06-20 | 2014-12-24 | L'oreal | Method for the densification of keratinous fibres based on specific acrylic polymer and specific silicone compound |
FR3007286A1 (en) * | 2013-06-20 | 2014-12-26 | Oreal | COMPOSITION COMPRISING THE ASSOCIATION OF ACRYLIC POLYMER, SILICONE COPOLYMER AND AMINO ACID OR AMINO ACID DERIVATIVE |
FR3007285A1 (en) * | 2013-06-20 | 2014-12-26 | Oreal | PROCESS FOR THE DENSIFICATION OF KERATINIC FIBERS BASED ON PARTICULATE ACRYLIC POLYMER AND SILICONE COMPOUND |
WO2014202655A1 (en) * | 2013-06-20 | 2014-12-24 | L'oreal | Composition comprising a combination of an acrylic polymer, a silicone copolymer and an amino acid or amino acid derivative |
US10159639B2 (en) | 2013-06-20 | 2018-12-25 | L'oreal | Composition comprising a combination of an acrylic polymer and an amino silicone |
US11166902B2 (en) | 2013-06-20 | 2021-11-09 | L'oreal | Composition comprising a combination of an acrylic polymer, a silicone copolymer and an amino acid or amino acid derivative |
FR3015244A1 (en) * | 2013-12-23 | 2015-06-26 | Oreal | PROCESS FOR TREATING KERATIN FIBERS WITH ASCORBIC ACID COMPOUND |
US11628148B2 (en) | 2017-07-10 | 2023-04-18 | Wella Operations Us, Llc | Nail hardening composition and method of use |
US11890262B2 (en) | 2017-07-10 | 2024-02-06 | Wella Operations Us, Llc | Nail hardening composition and method of use |
Also Published As
Publication number | Publication date |
---|---|
DE69723476D1 (en) | 2003-08-14 |
AR013328A1 (en) | 2000-12-27 |
CN1163215C (en) | 2004-08-25 |
JP2001525822A (en) | 2001-12-11 |
AU4999197A (en) | 1998-12-08 |
EP0981318B1 (en) | 2003-07-09 |
ATE244549T1 (en) | 2003-07-15 |
ES2202593T3 (en) | 2004-04-01 |
EP0981318A1 (en) | 2000-03-01 |
KR20010012619A (en) | 2001-02-26 |
RU2197946C2 (en) | 2003-02-10 |
CA2289505A1 (en) | 1998-11-19 |
AU746554B2 (en) | 2002-05-02 |
US6013250A (en) | 2000-01-11 |
DE69723476T2 (en) | 2004-05-13 |
CN1254276A (en) | 2000-05-24 |
PL336840A1 (en) | 2000-07-17 |
CA2289505C (en) | 2002-12-31 |
BR9714720A (en) | 2000-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU746554B2 (en) | Composition for treating hair | |
US5681554A (en) | Composition for treating hair and method for using the same | |
AU2017251818B2 (en) | Keratin Treatment Formulations and Methods | |
CA1320683C (en) | Hair treatment composition | |
EA035975B1 (en) | Method and formulation for treating hair when bleaching or coloring | |
US20160310394A1 (en) | Methods for Treating Relaxed Hair | |
JPH0539211A (en) | Reducing agent and cosmetic for human hair | |
CA1077850A (en) | Sulfites and mink oil fatty acid quaternary ammonium salt for treating hair | |
US5942009A (en) | Same-day waving and coloring of hair | |
WO2018020431A1 (en) | Topical cosmetic composition for restructuring and protecting hair and scalp, and uses thereof | |
CN112236126B (en) | Hair treatment method | |
JP7169623B2 (en) | Cosmetic containing arginine ester | |
JPS59101414A (en) | Hair-protecting cosmetic composition | |
JPH02212410A (en) | Composition agent for conditioning alkali-treated hair | |
EA042965B1 (en) | HAIR TREATMENT METHOD | |
JPH0597635A (en) | Method for treating hair | |
EA040937B1 (en) | REDUCING OR PREVENTING HAIR DAMAGE DURING LIGHTENING | |
JPS62138415A (en) | Hair cosmetic | |
NZ764434B2 (en) | Keratin Treatment Formulations and Methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 97182192.5 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1997912925 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2289505 Country of ref document: CA Ref document number: 2289505 Country of ref document: CA Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 1998 549192 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019997010579 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1997912925 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1019997010579 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1019997010579 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1997912925 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997912925 Country of ref document: EP |